Over the past years, this partnering and business development conference has given global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations, and learn about relevant CNS disease issues that will affect the industry.

However, with the unmet need for CNS treatments growing, it is time to reevaluate how we partner with other stakeholders in the field to accelerate research. We will discuss research consortia, collaborations between academic centers and industry, and the growing role of patient groups and foundations. This meeting creates a space for leaders in the field to gather and invest in partnerships that will accelerate research and move the field forward.

This conference is a part of the larger CNS Diseases World Summit 2013, which also includes the 7th Neurodegenerative Conditions Research & Development Conference. Sign up for a summit pass to get access to both conferences in the summit.

Sign up by 8 July 2013 for a 20 percent discount. Or register 3 for the price of 2 with the coupon code RCDVB.